Neoplasm Metastasis [clinicaltrials_resource:902e7d109524a3b1509836d6d7ada25f]
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas [clinicaltrials:NCT00001165]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial [clinicaltrials:NCT00001250]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [clinicaltrials:NCT00001302]Gene Therapy for the Treatment of Brain Tumors [clinicaltrials:NCT00001328]Direct Injection of Alcohol for the Treatment of Spinal Tumors [clinicaltrials:NCT00001417]A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [clinicaltrials:NCT00001436]Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [clinicaltrials:NCT00001440]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer [clinicaltrials:NCT00001570]A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [clinicaltrials:NCT00001576]A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [clinicaltrials:NCT00001683]Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase [clinicaltrials:NCT00001685]Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence [clinicaltrials:NCT00001705]clinicaltrials:NCT00001832Oxaliplatin in Cancer Patients With Impaired Kidney Function [clinicaltrials:NCT00001835]Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria [clinicaltrials:NCT00004988]Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas [clinicaltrials:NCT00023166]ADI-PEG in Patients With Metastatic Melanoma [clinicaltrials:NCT00029900]Study of Noni in Cancer Patients [clinicaltrials:NCT00033878]ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00034346]For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy [clinicaltrials:NCT00037180]Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma [clinicaltrials:NCT00055562]Study to Compare the Efficacy and Safety of CC-5013 Vs. Placebo in Subjects With Metastatic Malignant Melanoma. [clinicaltrials:NCT00057616]Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy [clinicaltrials:NCT00067314]Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases [clinicaltrials:NCT00068068]Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT00072865]Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors [clinicaltrials:NCT00075166]Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) [clinicaltrials:NCT00076856]Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases [clinicaltrials:NCT00083785]Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer [clinicaltrials:NCT00083993]Study of NS-9 in Patients With Liver Metastases [clinicaltrials:NCT00094003]A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain [clinicaltrials:NCT00099177]A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease [clinicaltrials:NCT00099203]ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00101920]A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer [clinicaltrials:NCT00102895]
condition [clinicaltrials_vocabulary:condition]
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas [clinicaltrials:NCT00001165]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial [clinicaltrials:NCT00001250]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [clinicaltrials:NCT00001302]Gene Therapy for the Treatment of Brain Tumors [clinicaltrials:NCT00001328]Direct Injection of Alcohol for the Treatment of Spinal Tumors [clinicaltrials:NCT00001417]A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [clinicaltrials:NCT00001436]Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [clinicaltrials:NCT00001440]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer [clinicaltrials:NCT00001570]A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [clinicaltrials:NCT00001576]A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [clinicaltrials:NCT00001683]Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase [clinicaltrials:NCT00001685]Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence [clinicaltrials:NCT00001705]clinicaltrials:NCT00001832Oxaliplatin in Cancer Patients With Impaired Kidney Function [clinicaltrials:NCT00001835]Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [clinicaltrials:NCT00002503]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002622Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors [clinicaltrials:NCT00002647]Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases [clinicaltrials:NCT00002655]Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00002692]Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases [clinicaltrials:NCT00002708]clinicaltrials:NCT00002716Monoclonal Antibody Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002751]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers [clinicaltrials:NCT00002752]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [clinicaltrials:NCT00002764]Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer [clinicaltrials:NCT00002793]clinicaltrials:NCT00002842Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions [clinicaltrials:NCT00002872]Adjuvant Radiation Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002899]SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [clinicaltrials:NCT00002960]Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer [clinicaltrials:NCT00002997]Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix [clinicaltrials:NCT00003065]Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer [clinicaltrials:NCT00003162]
condition browse [clinicaltrials_vocabulary:condition-browse]
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas [clinicaltrials:NCT00001165]A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [clinicaltrials:NCT00001193]Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial [clinicaltrials:NCT00001250]Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer [clinicaltrials:NCT00001269]Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [clinicaltrials:NCT00001270]A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [clinicaltrials:NCT00001302]Gene Therapy for the Treatment of Brain Tumors [clinicaltrials:NCT00001328]Direct Injection of Alcohol for the Treatment of Spinal Tumors [clinicaltrials:NCT00001417]A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [clinicaltrials:NCT00001436]Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy [clinicaltrials:NCT00001440]Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [clinicaltrials:NCT00001493]Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer [clinicaltrials:NCT00001507]A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer [clinicaltrials:NCT00001570]A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [clinicaltrials:NCT00001576]A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [clinicaltrials:NCT00001683]Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase [clinicaltrials:NCT00001685]Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence [clinicaltrials:NCT00001705]clinicaltrials:NCT00001832Oxaliplatin in Cancer Patients With Impaired Kidney Function [clinicaltrials:NCT00001835]Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [clinicaltrials:NCT00002503]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002622Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors [clinicaltrials:NCT00002647]Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases [clinicaltrials:NCT00002655]Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00002692]Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases [clinicaltrials:NCT00002708]clinicaltrials:NCT00002716Monoclonal Antibody Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002751]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers [clinicaltrials:NCT00002752]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [clinicaltrials:NCT00002764]Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer [clinicaltrials:NCT00002793]clinicaltrials:NCT00002842Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions [clinicaltrials:NCT00002872]Adjuvant Radiation Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002899]SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [clinicaltrials:NCT00002960]Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer [clinicaltrials:NCT00002997]Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix [clinicaltrials:NCT00003065]Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer [clinicaltrials:NCT00003162]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Neoplasm Metastasis [clinicaltrials_resource:902e7d109524a3b1509836d6d7ada25f]
Bio2RDF identifier
902e7d109524a3b1509836d6d7ada25f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:902e7d109524a3b1509836d6d7ada25f
identifier
clinicaltrials_resource:902e7d109524a3b1509836d6d7ada25f
title
Neoplasm Metastasis
@en
type
label
Neoplasm Metastasis [clinicaltrials_resource:902e7d109524a3b1509836d6d7ada25f]
@en
Neoplasm Metastasis